Form 8-K - Current report:
SEC Accession No. 0000912282-15-000010
Filing Date
2015-01-07
Accepted
2015-01-07 13:47:12
Documents
3
Period of Report
2015-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 antriabio8k_01072015.htm 8-K 25877
2 PRESS RELEASE DATED JANUARY 7, 2015 ex99_1.htm EX-99.1 10210
3 antriabiologo.jpg GRAPHIC 6720
  Complete submission text file 0000912282-15-000010.txt   46630
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 15513026
SIC: 2834 Pharmaceutical Preparations